| 1942 |
Established in 1942 as an export control company for Toyama household medicines. Founded Daito Pharmaceutical Trading Control Co., Ltd. |
| 1942 |
Established as an export control company for Toyama household medicines targeting Southeast Asia, where many Japanese residents lived. Founded Daito Pharmaceutical Trading Control Co., Ltd. |
| 1942-06 |
Founded in June 1942. |
| 1948 |
Changed the company name to Daito Trading Co., Ltd. in 1948. |
| 1948 |
Changed the company name to Daito Trading Co., Ltd. |
| 1949 |
Started manufacturing of dispensed pharmaceuticals in 1949. |
| 1949 |
Started manufacturing dispensed pharmaceuticals. |
| 1950 |
Opened a raw material wholesale division and began sales of active pharmaceutical ingredients in 1950. |
| 1961 |
The national health insurance system started in 1961, leading to widespread medical care. |
| 1971 |
Established a research institute in Toyama City in 1971. |
| 1971 |
Established a research institute in Toyama City. |
| 1976 |
Started manufacturing of generic pharmaceuticals in 1976. |
| 1976 |
Started manufacturing of generic pharmaceuticals. |
| 1979 |
Started manufacturing of active pharmaceutical ingredients in 1979. |
| 1979 |
Started manufacturing of active pharmaceutical ingredients. |
| 1985 |
Started manufacturing OTC pharmaceuticals in 1985. |
| 1985 |
Started manufacturing OTC pharmaceuticals. |
| 1987 |
Made Daiwa Pharmaceutical Industry Co., Ltd. (current name: Daito Corporation, Shimo-Oku Industrial Plant) a subsidiary in 1987. |
| 1987 |
Made Daiwa Pharmaceutical Industry Co., Ltd. (current name: Daito Corporation, Shimo-Oku Industrial Plant) a subsidiary. |
| 1989 |
Started contract manufacturing of new drug intermediates in 1989. |
| 1989 |
Started contract manufacturing of new drug intermediates. |
| 1991 |
Changed the company name to Daito Corporation (current name) in 1991. |
| 1991 |
Changed the company name to Daito Corporation. |
| 1993 |
Established a third manufacturing building in 1993. |
| 1993 |
Established a third manufacturing building. |
| 1999 |
Established a third active pharmaceutical ingredient building in 1999. |
| 1999 |
Established a third active pharmaceutical ingredient building. |
| 2001 |
Expanded contract manufacturing of prescription pharmaceuticals following the enforcement of revised Pharmaceutical Affairs Law in 2005. |
| 2007 |
Listed on the Tokyo Stock Exchange First Section in 2007. |
| 2007 |
Established a fifth active pharmaceutical ingredient building. |
| 2007 |
Made Daiwa Pharmaceutical Industry Co., Ltd. (current name: Daito Corporation, Shimo-Oku Industrial Plant) a wholly owned subsidiary. |
| 2008 |
Established Daito Pharmaceuticals America, Inc. in Illinois, USA in 2008. |
| 2008 |
Established Daito Pharmaceuticals America, Inc. in Illinois, USA. |
| 2008 |
Established the sixth manufacturing building. |
| 2010 |
Listed on the Tokyo Stock Exchange Second Section in 2010. |
| 2010 |
Listed on the Tokyo Stock Exchange Second Section. |
| 2011 |
Transferred to the Tokyo Stock Exchange First Section in 2011. |
| 2011 |
Transferred to the Tokyo Stock Exchange First Section. |
| 2012 |
Made Anhui Micro Nano Life Science Technology Development Co., Ltd. (current: Daito Pharmaceutical (China) Co., Ltd.) a subsidiary in 2012. |
| 2012 |
Made Anhui Micro Nano Life Science Technology Development Co., Ltd. a subsidiary. |
| 2014 |
Established a formulation building at Daito Pharmaceutical (China) Co., Ltd. in 2014. Built the seventh manufacturing building for high pharmacological activity pharmaceuticals. |
| 2014 |
Established a formulation building at Daito Pharmaceutical (China) Co., Ltd. |
| 2014 |
Established the seventh manufacturing building for high pharmacological activity pharmaceuticals. |
| 2014 |
Established the first factory building of Daiwa Pharmaceutical Industry (current name: Daito Corporation, Shimo-Oku Industrial Plant). |
| 2015 |
Transitioned from a company with a Board of Auditors to a company with an Audit and Supervisory Committee in 2015. |
| 2015 |
Transitioned from a company with a Board of Auditors to a company with an Audit and Supervisory Committee. |
| 2015 |
Established the sixth active pharmaceutical ingredient building. |
| 2017 |
Established a high pharmacological R&D center in 2017. |
| 2017 |
Established a high pharmacological R&D center. |
| 2018 |
Built the eighth manufacturing building for high pharmacological activity pharmaceuticals in 2018. |
| 2018 |
Established the eighth manufacturing building for high pharmacological activity pharmaceuticals. |
| 2020 |
Celebrated the 10th anniversary of stock listing. |
| 2021 |
Established a quality assurance building in 2021. |
| 2021 |
Established a quality assurance building. |
| 2022 |
Moved to the Prime Market following the review of market categories by the Tokyo Stock Exchange in 2022. |
| 2022 |
Moved to the Prime Market following the review of market categories by the Tokyo Stock Exchange. |
| 2022 |
Established the seventh active pharmaceutical ingredient building. |
| 2023 |
Built the tenth manufacturing building in 2023. |
| 2023 |
Established the tenth manufacturing building. |
| 2024 |
Established a comprehensive research center in 2024. |
| 2024 |
Established a comprehensive research center. |
| 2025 |
Merged with Daiwa Pharmaceutical Industry Co., Ltd. (current name: Daito Corporation, Shimo-Oku Industrial Plant) in 2025. |
| 2025 |
Merged with Daiwa Pharmaceutical Industry Co., Ltd. |
